The Société Francophone du Diabète (SFD) is seeking the expertise of Adkins Biosciences and two other leaders in the French biobanking ecosystem to accelerate the identification of new factors associated with major adverse cardiovascular events (MACE) in patients.
With this new mission, Adkins Biosciences is committed to optimizing the efficient and standardized management of all biobanking processes used to build the SFDT-1 biospecimen collection.